Six-Month Mortality among HIV-Infected Adults Presenting for Antiretroviral Therapy with Unexplained Weight Loss, Chronic Fever or Chronic Diarrhea in Malawi

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  van Lettow, Monique ^a,b   Åkesson, Ann ^c   Martiniuk, Alexandra L C ^a,b,d   Ramsay, Andrew ^e,f   Chan, Adrienne K ^a,b   Anderson, Suzanne T ^g,h   Harries, Anthony D ^i,j   Corbett, Elizabeth ^g,j   Heyderman, Robert S ^g   Zachariah, Rony ^c   Bedell, Richard A ^a,k  

^a DIGNITAS INTERNATIONAL   (Malawi)

^b UNIVERSITY OF TORONTO   (Canada)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF ST ANDREWS   (United Kingdom)

^g UNIVERSITY OF MALAWI   (Malawi)

^h BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

ⁱ INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANEMIA; ARTICLE; BLOODSTREAM INFECTION; CD4 LYMPHOCYTE COUNT; CHRONIC DIARRHEA; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT DURATION; TUBERCULOSIS; WEIGHT REDUCTION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; DIARRHEA; FEMALE; FEVER; HIV INFECTIONS; HUMANS; MALAWI; MALE; RISK FACTORS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; WEIGHT LOSS;

EID: 84869790025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048856     Document Type: Article

References (43)

1. Braitstein P, Brinkhof MW, Davis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 (9513): 81-24.
2. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22(15): 1897-908.
3. Lawn SD, Myer L, Orell C, Bekker LG, Wood R, (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implication for programme design. AIDS 19(18): 2141-8.
4. Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NFN, Guèye PM, et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20: 1181-89.
5. Lawn SD, Myer L, Harling G, Orell C, Bekker LG, et al. (2006) Determinants of mortality and non-death losses from an antiretroviral treatment service in South Africa: Implications for program evaluation. CID 43: 770-76.
6. Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, et al. (2010) Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa. AIDS 24(12): 1849-55.
7. Fairall LR, Bachmann MO, Louwagie MC, van Vuuren C, Chikobvu P, et al. (2008) Effectiveness of antiretroviral treatment in a South African program. Arch Intern Med 168: 86-93.
8. Lessels RJ, Mutevedzi PC, Heller T, Newell ML, (2011) Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S Afr Med J 101(4): 251-2.
9. Hill PC, Onyeama CO, Ikumapayi UNA, Secka O, Ameyaw S, et al. (2007) Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infectious Diseases 7: 2.
10. Reddy EA, Shaw AV, Crump JA, (2010) Community-acquired bloodstream infections in Africa: a systemic review and meta-analysis Lancet Infect Dis. 10(6): 417-32.
11. Jacob ST, Moore CC, Banura P, Pinkerton R, Meya D, et al. (2009) Severe sepsis in two Ugandan Hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population. PLoS ONE 4(11). Available: http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0007782. Accessed 2012 Jun 22.
12. Arthur G, Nduba VN, Kariuki SM, Kimari J, Bhatt SM, et al. (2001) Trends in blood steam infections among human immunodeficiency virus infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. CID 33: 248-56.
13. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS, (2009) Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 48(7): 856-62.
14. Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, et al. (2010) Autopsy causes of death in HIV-positive individuals in Sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 12: 183-94.
15. Ngoma D, Makombe SD, Kamoto K, Harries AD, (2008) World Health Organisation clinical stage 3 disease conditions in HIV-infected patients that start antiretroviral therapy in Malawi. Trop Doct 38(3): 159-60.
16. Bizuwork T, Makombe S, Kamoto K, Harries AD, (2007) WHO Stage 3 disease conditions and outcomes in patients started on antiretroviral therapy in Malawi. Journal of Infection in Developing Countries 1(2): 118-22.
17. Archibald LK, den Dulk MO, Pallangyo KJ, Reller LB, (1998) Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis 26(2): 290-6.
18. Archibald LK, McDonald LC, Nwanyanwu O, Kazembe P, Dobbie H, et al. (2000) A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis 181(4): 1414-20.
19. Bell M, Archibald LK, Nwanyanwu O, Dobbie H, Tokars J, et al. (2001) Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis (2): 63-9.
20. Lewis DK, Peters RP, Schijffelen MJ, Joaki GR, Walsh AL, et al. (2002) Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. Int J Tuberc Lung Dis 6(12): 1067-74.
21. Liechty CA, Solberg P, Were W, Ekwaru JP, Ransom RL, et al. (2007) Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 12(8): 929-35.
22. McDonald LC, Archibald LK, Rheanpumikankit S, Tansuphaswadikul S, Eampokalap B, et al. (1999) Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet 354(9185): 1159-63.
23. Ssali FN, Kamya MR, Wabwire-Mangen F, Kasasa S, Joloba M, et al. (1998) A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol 19(5): 484-9.
24. Westreich D, MacPhail P, Van Rie A, et al. (2009) Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS 23: 707-15.
25. Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, et al. (2012) Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 15(5): 571-81.
26. Everett DB, Mukaka M, Denis B, Gordon SB, Carrol ED, et al. (2011) Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One Mar 5 6(3): e17765.
27. Bedell RA, Anderson STB, van Lettow M, Åkesson A, Corbett EL, et al. (2012) High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi. PLoS ONE. Available: http://dx.plos.org/10.1371/journal.pone.0039347. Accessed 2012 Jun 22.
28. Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, et al. (2011) Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Int J Tuberc Lung Dis 15(12): 1663-9.
29. Malawi Ministry of Health (2007) HIV and syphilis sero-survey and national HIV prevalence and AIDS estimates report 2007. Lilongwe, Malawi: National AIDS Commission.
30. Government of Malawi Ministry of Health, with technical support from SACEMA and WHO (2012) Impact Assessment for ART, TB treatment and PMTCT, Using Triangulation Approach. Final Report April 2012. Lilongwe, Malawi.
31. Vittinghoff E, McCulloch CE, (2007) Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression. Am J Epidemiol 165(6): 710-718.
32. Lévesque LE, Hanley JA, Kezouh A, Suissa S, (2010) Problem of immortal time bias in cohort studies: example of using statins for preventing progression of diabetes BMJ. 340: 907-11.
33. Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, et al. (2011) Use of WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis 11: 533-40.
34. Lawn SD, Török ME, Wood R, (2011) Optimal time to start antiretroviral therapy during HIV-associated opportunistic infections. Curr Opin Infect Dis 24: 34-42.
35. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. (2011) Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis. N Engl J Med 365: 1471-1481.
36. Kerkhoff AD, Wood R, Lawn SD, (2011) Optimal time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis? AIDS 25(7): 1003-6.
37. Stall N, Rubin T, Michael JS, Mathai D, Abraham OC, et al. (2011) Does solid culture for tuberculosis influence clinical decision making in India? Int J Tuberc Lung Dis 15(5): 651-646.
38. Lawn SD, Canbell L, Kaplan R, Bouelle A, Cornell M, et al. (2011) Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa J Acquir Immune Defic Syndr. 57(2): 136-40.
39. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, et al. (2001) Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16: 1633-41.
40. Mayanja BN, Todd J, Hughes P, Van der Paal L, Mugisha JO, et al. (2010) Septicaemia in a population-based HIV cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact on antiretroviral therapy. Trop Med Int Health 15(6): 697-705.
41. Muyanja SZ, Larke N, Rutebarika D, Kaddu I, Nakubulwa S, et al. (2011) Decreasing trends in bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008). Trop Med Int Health 16(6): 756-65.
42. Peters RP, Zijlistra EE, Schijffelen MJ, Walsh AL, Joaki G, et al. (2004) A Prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Trop Med Int Health 9(8): 928-34.
43. Yu JKL, Chen SCC, Wang KY, Chang CS, Makombe SD, et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull Word Health Organ 85(7): 550-554.